Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 5,000 shares at $30.37 ($153K) on 2022-04-11, disclosed to the SEC on 2022-04-13.
Open-market sale of $153k ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.37 | 4,600 | $140K | 91.5% |
| 2 | $32.40 | 300 | $10K | 6.4% |
| 3 | $33.16 | 100 | $3K | 2.2% |
| Total | $30.55 avg | 5,000 | $153K | 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |